-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $28

Benzinga·11/10/2026 12:14:56
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $25 to $28.